42Stockpicking

OFIX

Orthofix Medical Inc
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
1,0
7th %ile · 404p
P/Si
0,3
7th %ile · 356p
EV/Salesi
0,2
4th %ile · 356p
Div yieldi

Kursudvikling

Kun 82 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
82
Årsregnskaber
18
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-09 til 2026-06-05

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

OFIX vurderet 2026-06-10

Score
52.9%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

67%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

68%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

22%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

66%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

53%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

68%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
238.330
Net 90d (værdi)
2.554.782 USD
Købere 90d
1
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.6.2026McPherron AvivaPres, Global Ops & Qual▼ SALG-3.670-34.425 USDsec
10.6.2026Paolucci Michael E· ANDET14.965sec
10.6.2026Maniar Shweta· ANDET14.965sec
10.6.2026BURRIS WAYNE· ANDET14.965sec
10.6.2026HENNEMAN JOHN B III· ANDET14.965sec
10.6.2026Finegan Michael· ANDET20.721sec
10.6.2026Hannon Jason· ANDET14.965sec
10.6.2026Kummeth Charles R.· ANDET14.965sec
10.6.2026Bazaar Alan Lee· ANDET14.965sec
10.6.2026CAPPS VICKIE L· ANDET14.965sec
22.5.2026▼ SALG242.0002.589.206 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,11-0,29+61.0%+61.0%Beat
2025Q430.1.20260,240,42-42.7%-42.7%Miss
2025Q330.10.20250,200,12+64.7%+64.7%Beat
2025Q230.7.20250,130,04+223.5%+223.5%Beat